ACIU
Income statement / Annual
Last year (2024), AC Immune SA's total revenue was $27.31 M,
an increase of 84.51% from the previous year.
In 2024, AC Immune SA's net income was -$50.92 M.
See AC Immune SA,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$27.31 M |
$14.80 M |
$3.94 M |
$0.00 |
$15.43 M |
$111.03 M |
$7.19 M |
$20.26 M |
$23.21 M |
$39.09 M |
| Cost of Revenue |
$0.00
|
$54.61 M
|
$60.34 M
|
$62.28 M
|
$59.49 M
|
$50.43 M
|
$44.28 M
|
$32.66 M
|
$25.77 M
|
$17.05 M
|
| Gross Profit |
$27.31 M
|
-$39.81 M
|
-$56.40 M
|
-$62.28 M
|
-$44.06 M
|
$60.59 M
|
-$37.08 M
|
-$12.41 M
|
-$2.56 M
|
$22.04 M
|
| Gross Profit Ratio |
1
|
-2.69
|
-14.33
|
0
|
-2.86
|
0.55
|
-5.15
|
-0.61
|
-0.11
|
0.56
|
| Research and Development Expenses |
$62.57 M
|
$54.61 M
|
$60.34 M
|
$62.28 M
|
$59.49 M
|
$50.43 M
|
$44.28 M
|
$32.66 M
|
$25.77 M
|
$17.05 M
|
| General & Administrative Expenses |
$11.43 M
|
$10.58 M
|
$15.79 M
|
$10.88 M
|
$11.09 M
|
$9.42 M
|
$7.56 M
|
$6.27 M
|
$4.73 M
|
$2.04 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$11.43 M
|
$10.58 M
|
$15.79 M
|
$10.88 M
|
$11.09 M
|
$9.42 M
|
$7.56 M
|
$6.27 M
|
$4.73 M
|
$2.04 M
|
| Other Expenses |
$5.68 M
|
-$51.36 M
|
-$1.34 M
|
$5.85 M
|
$6.12 M
|
$6.64 M
|
$4.90 M
|
$3.86 M
|
$3.17 M
|
$1.38 M
|
| Operating Expenses |
$79.69 M
|
$13.82 M
|
$74.78 M
|
$79.01 M
|
$76.69 M
|
$66.49 M
|
$56.74 M
|
$42.79 M
|
$33.67 M
|
$20.47 M
|
| Cost And Expenses |
$79.69 M
|
$68.43 M
|
$74.78 M
|
$79.01 M
|
$76.69 M
|
$66.49 M
|
$56.74 M
|
$42.79 M
|
$33.67 M
|
$20.47 M
|
| Interest Income |
$3.20 M
|
$1.04 M
|
$69,000.00
|
$6.49 M
|
$78,000.00
|
$304,000.00
|
$29,000.00
|
$330,000.00
|
$43,000.00
|
$55,000.00
|
| Interest Expense |
$133,000.00
|
$176,000.00
|
$355,000.00
|
$581,000.00
|
$184,000.00
|
$1.89 M
|
$298,000.00
|
$147,000.00
|
$256,000.00
|
$26,000.00
|
| Depreciation & Amortization |
$2.16 M
|
$2.22 M
|
$2.36 M
|
$1.90 M
|
$1.97 M
|
$1.69 M
|
$961,000.00
|
$580,000.00
|
$278,000.00
|
$287,000.00
|
| EBITDA |
-$48.62 M |
-$51.83 M |
-$69.05 M |
-$77.11 M |
-$61.26 M |
$44.54 M |
-$49.66 M |
-$22.54 M |
-$6.81 M |
$18.91 M |
| EBITDA Ratio |
-1.78
|
-3.5
|
-17.99
|
0
|
-3.84
|
0.42
|
-6.74
|
-1.07
|
-0.28
|
0.53
|
| Operating Income Ratio |
-1.92
|
-3.62
|
-18
|
0
|
-3.97
|
0.4
|
-6.89
|
-1.11
|
-0.45
|
0.48
|
| Total Other Income/Expenses Net |
$1.47 M
|
-$599,000.00
|
$107,000.00
|
$6.02 M
|
-$661,000.00
|
$906,000.00
|
-$1.40 M
|
-$3.87 M
|
$3.36 M
|
$1.65 M
|
| Income Before Tax |
-$50.91 M
|
-$54.22 M
|
-$70.74 M
|
-$72.99 M
|
-$61.92 M
|
$45.44 M
|
-$50.95 M
|
-$26.41 M
|
-$7.10 M
|
$20.27 M
|
| Income Before Tax Ratio |
-1.86
|
-3.66
|
-17.98
|
0
|
-4.01
|
0.41
|
-7.08
|
-1.3
|
-0.31
|
0.52
|
| Income Tax Expense |
$3,000.00
|
$10,000.00
|
$13,000.00
|
$3,000.00
|
$184,000.00
|
$1.89 M
|
-$1.10 M
|
$147,000.00
|
$3.62 M
|
$1.64 M
|
| Net Income |
-$50.92 M
|
-$54.23 M
|
-$70.75 M
|
-$73.00 M
|
-$62.11 M
|
$45.44 M
|
-$50.95 M
|
-$26.41 M
|
-$7.10 M
|
$20.27 M
|
| Net Income Ratio |
-1.86
|
-3.66
|
-17.98
|
0
|
-4.02
|
0.41
|
-7.08
|
-1.3
|
-0.31
|
0.52
|
| EPS |
-0.46 |
-0.64 |
-0.85 |
-0.97 |
-0.86 |
0.64 |
-0.82 |
-0.46 |
-0.14 |
0.37 |
| EPS Diluted |
-0.5 |
-0.64 |
-0.85 |
-0.97 |
-0.86 |
0.64 |
-0.82 |
-0.46 |
-0.14 |
0.37 |
| Weighted Average Shares Out |
$110.06 M
|
$84.69 M
|
$83.55 M
|
$74.95 M
|
$71.90 M
|
$70.60 M
|
$61.84 M
|
$57.08 M
|
$50.10 M
|
$55.40 M
|
| Weighted Average Shares Out Diluted |
$100.86 M
|
$84.69 M
|
$83.55 M
|
$74.95 M
|
$71.90 M
|
$71.10 M
|
$61.84 M
|
$57.36 M
|
$50.10 M
|
$55.40 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
